Bone graft membrane helps prevent fracture in J.J. Watt
Watt is one of the best football players in the NFL.
He’s been playing for the Kansas City Chiefs since 2011, and he has yet to record a single sack or fumble.
He has been sacked 11 times, fumbled five times and forced a fumble once, per Pro Football Focus.
So how did Watt get so many fumbles?
According to a new study published in the Journal of Bone and Mineral Research, the answer is not the same bone graft fluid he was born with.
The team from New York State Polytechnic Institute and State University of New York in Syracuse, found that the fluid used to heal a bone graft is not as effective as a bone-gel type fluid that can be made by a doctor.
The study looked at the effectiveness of different graft types and found that bone graft membranes were significantly less effective than bone gel membranes for preventing fractures, even though they are commonly used.
The membrane is the thick, flexible part of a graft that allows the patient to stretch and stretch out, which in turn causes the graft to stretch.
The researchers found that gel-like fluids, which are less than 1 percent of the fluid that the bone grafts are made from, are much more effective at preventing fractures.
They also found that those who use gel-type fluids had higher levels of bone turnover and were more likely to have a fracture.
The results suggest that bone-graft membranes may be a more effective option for preventing fracture than bone- gel fluid, the researchers said.
They believe this could have implications for the way players are trained to heal fractures, which can be difficult and expensive to repair.
“Our study demonstrates that there are limitations to using the fluid to replace a graft, especially given the high levels of injury, but that the efficacy of the gel-based graft membrane is superior to the bone-filled graft membrane,” said lead researcher Ravi Kulkarni, PhD, an assistant professor in the department of clinical medicine and epidemiology at the NYU School of Medicine.
The findings also have implications in the rehabilitation of patients who are injured on the field, the authors wrote.
“These results demonstrate that using a gel- or gel-gel-type fluid to relieve pressure on the bone during joint re-acclimation may be beneficial for athletes who suffer from injury, particularly for athletes with compromised healing capacities.”
For the study, Kulkavli and colleagues recruited 20 athletes, ages 15 to 30, who had sustained a single fractured bone in their right knee.
All athletes were then given a standardized treatment called a “bone graft membrane” that consisted of a mesh of fibrous gel that allowed them to stretch the joint during recovery.
After the athletes had recovered from the injury, the mesh was replaced with a “gel-like fluid” called a graft membrane that included bone-like tissue.
The mesh was then placed over the injured area, and the gel was removed.
The gel-and-gel group had a higher risk of fractures, with 17.8 percent of them experiencing a fracture and 12.5 percent of all participants reporting a fracture during their recovery.
Those who used the gel had a lower fracture risk of 6.9 percent compared with their gel- and gel-filled group.
“This study suggests that using gel-containing fluid during joint recovery may be advantageous for athletes recovering from injury,” Kulkava said.
“The results support the hypothesis that fluid-based fluid should be used in conjunction with a gel or gel mixture to provide additional support and stabilization for the injured joint during joint rehabilitation.”
Kulkvili also noted that the results are not meant to suggest that using the gel as the sole fluid to treat injuries would be a safe practice.
“We need to make sure that the use of gel-grafted fluids is as safe and as effective for athletes as possible,” Kukkarni said.
But, if patients are looking for a treatment that will protect their knees, he said, “the gel-made graft membrane should be considered.”
“These findings demonstrate that there is a need to develop better fluid replacement therapies to address the osteoarthritis and post-inflammatory pain associated with joint injuries,” Kankarni concluded.
“However, this study has some limitations.
For example, it was not designed to assess the effectiveness and safety of gel and gel combination fluid therapy.
The next step in this study will be to evaluate the use and safety in a larger group of athletes with different injury histories.
Future research on this subject will help us better understand the mechanisms that cause the injuries and how they are prevented.”
This is an important step in the development of a fluid- and/or gel-derived gel-compatible treatment for osteoarthropathy and pain.